AGH Wealth Advisors LLC Invests $213,000 in The Cigna Group (NYSE:CI)

by · The Cerbat Gem

AGH Wealth Advisors LLC purchased a new position in shares of The Cigna Group (NYSE:CI – Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 647 shares of the health services provider’s stock, valued at approximately $213,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Two Sigma Investments LP raised its stake in shares of The Cigna Group by 32.6% during the 4th quarter. Two Sigma Investments LP now owns 764,900 shares of the health services provider’s stock worth $211,219,000 after buying an additional 188,235 shares in the last quarter. Valley Wealth Managers Inc. raised its position in The Cigna Group by 2.8% in the fourth quarter. Valley Wealth Managers Inc. now owns 56,933 shares of the health services provider’s stock worth $15,721,000 after acquiring an additional 1,548 shares in the last quarter. Humankind Investments LLC lifted its holdings in The Cigna Group by 12.1% in the fourth quarter. Humankind Investments LLC now owns 5,294 shares of the health services provider’s stock valued at $1,462,000 after acquiring an additional 571 shares during the period. Kingsview Wealth Management LLC lifted its holdings in The Cigna Group by 11.0% in the fourth quarter. Kingsview Wealth Management LLC now owns 35,056 shares of the health services provider’s stock valued at $9,680,000 after acquiring an additional 3,484 shares during the period. Finally, Aubrey Capital Management Ltd boosted its position in shares of The Cigna Group by 91.8% during the 4th quarter. Aubrey Capital Management Ltd now owns 1,849 shares of the health services provider’s stock worth $511,000 after purchasing an additional 885 shares in the last quarter. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Activity

In other news, Director Elder Granger sold 2,376 shares of the company’s stock in a transaction on Friday, March 14th. The stock was sold at an average price of $310.35, for a total transaction of $737,391.60. Following the completion of the sale, the director now directly owns 5,471 shares in the company, valued at $1,697,924.85. This represents a 30.28% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 0.70% of the company’s stock.

The Cigna Group Stock Up 0.2%

Shares of NYSE CI opened at $310.79 on Friday. The firm has a market cap of $83.03 billion, a P/E ratio of 25.39, a price-to-earnings-growth ratio of 0.98 and a beta of 0.47. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66. The Cigna Group has a 1 year low of $262.03 and a 1 year high of $370.83. The firm’s 50 day moving average price is $323.77 and its 200 day moving average price is $309.22.

The Cigna Group (NYSE:CI – Get Free Report) last posted its quarterly earnings data on Friday, May 2nd. The health services provider reported $6.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.35 by $0.39. The business had revenue of $65.45 billion for the quarter, compared to analysts’ expectations of $60.39 billion. The Cigna Group had a return on equity of 18.61% and a net margin of 1.39%. The business’s revenue was up 14.4% on a year-over-year basis. During the same quarter last year, the firm earned $6.47 earnings per share. As a group, sell-side analysts anticipate that The Cigna Group will post 29.77 earnings per share for the current year.

The Cigna Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd will be issued a $1.51 dividend. This represents a $6.04 annualized dividend and a yield of 1.94%. The ex-dividend date of this dividend is Tuesday, June 3rd. The Cigna Group’s dividend payout ratio (DPR) is 33.44%.

Analyst Ratings Changes

CI has been the subject of a number of research analyst reports. Sanford C. Bernstein downgraded shares of The Cigna Group from an “outperform” rating to a “market perform” rating and set a $323.00 price target for the company. in a report on Thursday, February 6th. Cantor Fitzgerald lifted their price target on shares of The Cigna Group from $350.00 to $365.00 and gave the company an “overweight” rating in a research report on Thursday, March 20th. Royal Bank of Canada reissued an “outperform” rating and set a $371.00 price target on shares of The Cigna Group in a research note on Tuesday. Wall Street Zen raised The Cigna Group from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, April 8th. Finally, Guggenheim reaffirmed a “buy” rating and set a $388.00 price objective on shares of The Cigna Group in a report on Friday, May 23rd. Two research analysts have rated the stock with a hold rating, sixteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Buy” and a consensus target price of $380.39.

Read Our Latest Stock Analysis on The Cigna Group

The Cigna Group Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CI – Free Report).